OCD
Clinical trials for OCD explained in plain language.
Never miss a new study
Get alerted when new OCD trials appear
Sign up with your email to follow new studies for OCD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can continued therapy keep OCD symptoms at bay?
Disease control OngoingThis study offers open/aftercare treatment to adults with obsessive-compulsive disorder (OCD) who have completed an earlier study at Stanford's Rodriguez Lab. Participants receive evidence-based psychotherapy and/or pharmacotherapy from trained professionals. The goal is to see i…
Matched conditions: OCD
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Brain pacemaker trial targets Tough-to-Treat OCD
Disease control OngoingThis study tests a personalized deep brain stimulation (DBS) approach for people with severe obsessive-compulsive disorder (OCD) that hasn't improved with standard treatments. Ten adults will first undergo brain mapping to find the best stimulation targets, then receive a DBS dev…
Matched conditions: OCD
Phase: NA • Sponsor: Andrew Moses Lee, MD, PhD • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Could a Parkinson's drug tame OCD?
Symptom relief OngoingThis study tests whether tolcapone, a drug used for Parkinson's disease, can reduce symptoms of obsessive-compulsive disorder (OCD) in adults. About 49 people with moderate to severe OCD will receive either tolcapone or a placebo. The main goal is to see if the drug safely lowers…
Matched conditions: OCD
Phase: PHASE2 • Sponsor: University of Chicago • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC